EN DE
Watch Luff Enterprises Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Luff Enterprises Ltd (LUFFF) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of Luff Enterprises Ltd stock $0.02, price $0.02, upside +2.1%, quality 38 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Based in Canada

LE Luff Enterprises Ltd logo Thin data Nov 10, 2026

Luff Enterprises Ltd

LUFFF · US
Low Priority

The stock costs about what our calculation considers fair.

Low debt
Fair value $0.0204 · Fairly valued
Mixed Growth (revenue 3y +236.2 %/yr in USD)
Quality 38/100
Loss-making · -22.0% net margin (TTM)
Negative free cash flow
Trails peers (3/9)
Narrow moat 5/100 · thin data
Thin data
Estimate⚠ Thinly traded
Watch Luff Enterprises Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.4000 $0.0010 Fair Value $0.0204 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range $0.0010 – $0.4000 · fair‑value band $0.0193 – $0.0215 · the $0.0200 price screens below the $0.0204 fair value. As of Nov 10, 2026.

Follow Luff Enterprises in your weekly email

Every Wednesday you see whether Luff Enterprises is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Herbal Dispatch Inc., together with its subsidiaries, engages in the sale of cannabis and cannabis related products in Canada and internationally.

Show moreShow less

The company offers dried flowers, pre-rolls, concentrates, vapes, edibles, oils and capsules, topicals, CBD, seeds, and accessories, as well as small-batch craft and curated cannabis products. It also provides packaging and processing services.

The company sells its products under various brand names through cannabis e-commerce platforms. It exports its products. The company was founded in 2015 and is headquartered in Vancouver, Canada.

Stock analysis

Luff Enterprises Ltd (LUFFF) currently trades at $0.0200, while our estimate is $0.0204, so the stock looks roughly fairly valued today (gap 2.1%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $0.0193 (bear) to $0.0215 (bull), the price of $0.0200 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Luff Enterprises Ltd reported revenue of C$12.1M in FY2025 versus C$684K in FY2021, a compound +105.1%/yr. Reported net income was −C$1.8M in FY2025.

Key figures

Market cap $2.5M Micro · P/S ratio 0.18 · EPS (TTM) $−0.0100 · Net margin −15.2% · Return on equity −126% · Return on assets (EBIT) −27.3% (5-year average) · Operating margin −23.6% · Revenue (TTM) C$11.0M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 5 out of 100 (low confidence).

What moves the price

The share trades about 95% below its 52-week high and 90% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 2%, LUFFF screens cheaper than that median.

Fair Value

Bear $0.0193 Fair Value $0.0204 Bull $0.0215
Price $0.0200 · Upside +2.1%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 38/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 30
How much profit the company makes from its sales and capital
Quality Growth 87
Are margins and returns getting better?
Cashflow 14
Do the profits arrive as real cash?
Financial strength 33
Debt, balance sheet and risk of trouble
Investment 97
Does it invest with discipline instead of growing at any price?
Low Volatility 16
How calm the share price moves, does not count
Price momentum 38
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 51
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 36/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+22.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+236.2%
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+46.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−20,408.4% (2020) → −10.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch LUFFF, get fair value alerts →

Compare Luff Enterprises Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 606 stocks

Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 38 · Bottom 25%
Fair Value upside +2.0% · Above median
Profitability
Return on assets −21.8% · Bottom 25%
Net margin (12 months) −22.0% · Bottom 25%
Operating margin (12 months) −23.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −5.2% · Below median
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B 1.18× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 0.33× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)36 · sector 18
FUTURE (revenue growth)0 · sector 25
PAST (return on equity)0 · sector 25
HEALTH (low debt)99 · sector 96
DIVIDEND (yield)0 · sector 31

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Zoetis Inc ZTS $82.46 $113.53 +38% vs LUFFF
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥48.55 ¥55.21 +14% vs LUFFF
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,905 ₹1,983 +4% vs LUFFF
Haleon plc HLN $9.06 $8.62 −5% vs LUFFF
Merck KGaA MRK €149.35 €109.18 −27% vs LUFFF
Galderma Group GALD CHF 188.55 CHF 109.80 −42% vs LUFFF
Takeda Pharmaceutical Company TAK $20.93 $11.34 −46% vs LUFFF
Teva Pharmaceutical Industries Limited TEVA $42.40 $20.74 −51% vs LUFFF
Sandoz Group SDZ CHF 83.38 CHF 39.70 −52% vs LUFFF
Divi's Laboratories Limited DIVISLAB ₹11,566 ₹1,567 −86% vs LUFFF

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Luff Enterprises Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Luff Enterprises Ltd Fair Value". https://www.fairvalue-calculator.com/stock/LUFFF

Frequently asked questions

Is Luff Enterprises Ltd (LUFFF) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $0.0204 versus a price of $0.0200, about +2% upside (fairly valued).
What is the fair value of LUFFF?
Our estimate for Luff Enterprises Ltd is $0.0204 (as of Nov 10, 2026), built from audited fundamentals. The current price: $0.0200.
What is the quality score of LUFFF?
Luff Enterprises Ltd has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Luff Enterprises Ltd (LUFFF)?
Our calculated price target is the estimate of $0.0204 (as of Nov 10, 2026). Cautious scenario $0.0193, optimistic scenario $0.0215. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Luff Enterprises Ltd stock forecast for 2026?
Our estimate puts fair value at $0.0204, about +2% upside versus a price of $0.0200 (fairly valued). Cautious scenario $0.0193, optimistic scenario $0.0215. The calculation is refreshed regularly with new filings.
What is the revenue of Luff Enterprises Ltd (LUFFF)?
Luff Enterprises Ltd reported trailing-twelve-month revenue of about C$11.0M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Luff Enterprises Ltd (LUFFF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Luff Enterprises Ltd it is $0.0204 per share (as of Nov 10, 2026), against a price of $0.0200.
Is Luff Enterprises Ltd stock overvalued or undervalued in 2026?
As of Nov 10, 2026, LUFFF trades below its calculated fair value: price $0.0200, fair value $0.0204, a gap of about +2% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LUFFF?
No. The price is what the market pays today ($0.0200); the fair value is what the company's own numbers justify ($0.0204). For Luff Enterprises Ltd the two are $0.0004 per share apart. That gap is exactly why we show both numbers side by side.
How much is Luff Enterprises Ltd worth?
The market values Luff Enterprises Ltd at about $2.5M (market capitalisation, as of Nov 10, 2026). Per share that is $0.0200; our models calculate a fair value of $0.0204 per share.
What do the bullish and bearish scenarios say about LUFFF?
Our models span a range for Luff Enterprises Ltd: cautious scenario $0.0193, base $0.0204, optimistic $0.0215 per share (as of Nov 10, 2026, price $0.0200). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Luff Enterprises Ltd (LUFFF)?
Balance-sheet figures for Luff Enterprises Ltd (as of Nov 10, 2026): return on equity −125.9%, debt of 0.03 per unit of equity. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is LUFFF from its 52-week high?
Luff Enterprises Ltd trades at $0.0200, about 95% below its 52-week high of $0.4000 and 90% above the low of $0.0105 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0204 is for.
Which stocks are comparable to Luff Enterprises Ltd?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Galderma Group, Teva Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Luff Enterprises Ltd stock attractive at the current price?
The data as of Nov 10, 2026: price $0.0200, calculated fair value $0.0204 (+2%), Quality Score 38/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Luff Enterprises Ltd currently trades 2% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Luff Enterprises Ltd (LUFFF)?
The closing price on Nov 9, 2026 was $0.0200. Our estimate is $0.0204, about +2% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Luff Enterprises Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band ($0.0193 to $0.0215), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Luff Enterprises Ltd

How large is the market capitalisation of Luff Enterprises Ltd (LUFFF)?
The market capitalisation of Luff Enterprises Ltd is $2.5M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Luff Enterprises Ltd (LUFFF)?
The price-to-sales ratio of Luff Enterprises Ltd is 0.18 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Luff Enterprises Ltd (LUFFF)?
Earnings per share at Luff Enterprises Ltd are $−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Luff Enterprises Ltd (LUFFF)?
The net margin of Luff Enterprises Ltd is −15.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Luff Enterprises Ltd (LUFFF)?
The return on equity (ROE) of Luff Enterprises Ltd is −126% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Luff Enterprises Ltd (LUFFF)?
On an EBIT basis the return on assets of Luff Enterprises Ltd is −27.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Luff Enterprises Ltd (LUFFF)?
The operating margin of Luff Enterprises Ltd is −23.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Luff Enterprises Ltd (LUFFF)?
Revenue at Luff Enterprises Ltd is growing −5.2% versus a year earlier (3y avg +236%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Luff Enterprises Ltd (LUFFF) generate?
The free cash flow of Luff Enterprises Ltd is −C$2.1M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Luff Enterprises Ltd (LUFFF) carry?
The net debt of Luff Enterprises Ltd is C$1.5M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Luff Enterprises Ltd in the live analysis

One click puts Luff Enterprises Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.